Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Keywords: Type 2 DM
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 2165
Healthy volunteers: no

Brief summary:
The efficacy and safety study of saxagliptin 5mg, once daily for 24 weeks in patients with type 2 diabetes mellitus.

Detailed description:
A multicenter, single arm, cohort study to evaluate the Efficacy and Safety of saxagliptin 5mg, once daily for 24 weeks, in patients with type 2 diabetes mellitus who are treatment naive or who have inadequate glycaemic control on metformin alone

Arms:
arm 1: Saxagliptin, oral 5mg once a day(Q. D.)

Interventions: intervention 1: Saxagliptin
Intervention descriptions: intervention 1: oral, 5 mg once a day (Q.D.)

Protocol document: